Staphylococcus aureus adaptation biofilm cystic fibrosis evolution genomics infection

Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
15 03 2023
Historique:
pubmed: 28 2 2023
medline: 21 3 2023
entrez: 27 2 2023
Statut: ppublish

Résumé

Staphylococcus aureus generates biofilms during many chronic human infections, which contributes to its growth and persistence in the host. Multiple genes and pathways necessary for S. aureus biofilm production have been identified, but knowledge is incomplete, and little is known about spontaneous mutations that increase biofilm formation as infection progresses. Here, we performed

Identifiants

pubmed: 36847490
doi: 10.1128/iai.00538-22
pmc: PMC10016075
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0053822

Subventions

Organisme : NIAMS NIH HHS
ID : K23 AR080209
Pays : United States
Organisme : NIAMS NIH HHS
ID : L30 AR079800
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK089507
Pays : United States

Références

PLoS One. 2015 Apr 08;10(4):e0123027
pubmed: 25853849
Microbiol Mol Biol Rev. 2020 Aug 12;84(3):
pubmed: 32792334
Genome Res. 2014 May;24(5):839-49
pubmed: 24717264
Clin Infect Dis. 2019 Nov 13;69(11):1937-1945
pubmed: 30753350
FEMS Microbiol Lett. 2010 Apr;305(2):143-7
pubmed: 20199571
Int J Med Microbiol. 2018 Aug;308(6):558-568
pubmed: 29198880
J Bacteriol. 2009 Feb;191(3):832-43
pubmed: 19047354
Microorganisms. 2019 Nov 20;7(12):
pubmed: 31756969
PLoS Pathog. 2016 Nov 30;12(11):e1006024
pubmed: 27902784
Microbiol Spectr. 2022 Jun 29;10(3):e0052222
pubmed: 35588281
Front Cell Infect Microbiol. 2018 Feb 02;8:18
pubmed: 29456969
PLoS One. 2020 May 29;15(5):e0233973
pubmed: 32470063
Emerg Microbes Infect. 2018 Apr 25;7(1):72
pubmed: 29691368
Mol Microbiol. 2017 May;104(3):365-376
pubmed: 28142193
Nat Biotechnol. 2006 Jan;24(1):79-88
pubmed: 16369541
J Bacteriol. 2004 Jul;186(14):4665-84
pubmed: 15231800
Methods Mol Biol. 2007;391:127-44
pubmed: 18025674
Trends Microbiol. 2009 Feb;17(2):59-65
pubmed: 19208480
PLoS Pathog. 2018 Mar 15;14(3):e1006917
pubmed: 29543889
Proteomics. 2006 Mar;6(6):1867-77
pubmed: 16470655
Sci Rep. 2017 Dec 7;7(1):17183
pubmed: 29215019
J Microbiol Methods. 2000 Apr;40(2):175-9
pubmed: 10699673
Virulence. 2011 Sep-Oct;2(5):445-59
pubmed: 21921685
Infect Immun. 1999 Oct;67(10):5427-33
pubmed: 10496925
Infect Immun. 2019 Mar 25;87(4):
pubmed: 30670553
mBio. 2013 Feb 12;4(1):e00537-12
pubmed: 23404398
mBio. 2018 Feb 20;9(1):
pubmed: 29463653
Infect Immun. 2007 Mar;75(3):1079-88
pubmed: 17158901
J Med Microbiol. 2017 Apr;66(4):461-469
pubmed: 28463662
J Bacteriol. 2008 Apr;190(7):2257-65
pubmed: 18156263
Eur Respir J. 1999 Dec;14(6):1340-4
pubmed: 10624764
J Vis Exp. 2011 Jan 30;(47):
pubmed: 21307833
Am J Respir Crit Care Med. 2014 Apr 1;189(7):812-24
pubmed: 24467627
Nucleic Acids Res. 2016 Nov 2;44(19):9483-9493
pubmed: 27596595
J Bacteriol. 2000 Dec;182(23):6824-6
pubmed: 11073930
Front Cell Infect Microbiol. 2014 Dec 23;4:178
pubmed: 25566513
J Bacteriol. 2002 Aug;184(16):4400-8
pubmed: 12142410
J Bacteriol. 2020 Mar 26;202(8):
pubmed: 32015143
Biochemistry. 2020 Aug 11;59(31):2882-2895
pubmed: 32697076
Am J Respir Cell Mol Biol. 2019 Aug;61(2):185-197
pubmed: 30742488
PLoS One. 2011;6(9):e24301
pubmed: 21912685
J Bacteriol. 2005 Jun;187(12):4127-39
pubmed: 15937175
Int J Med Microbiol. 2014 Nov;304(8):1038-49
pubmed: 25129555
Int J Environ Res Public Health. 2021 Jul 16;18(14):
pubmed: 34300053
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1745-1754
pubmed: 30635416
Front Immunol. 2014 Feb 05;5:37
pubmed: 24550921
Curr Top Microbiol Immunol. 2008;322:207-28
pubmed: 18453278
JAC Antimicrob Resist. 2022 Feb 08;4(1):dlac011
pubmed: 35156034
J Infect Dis. 2005 Sep 15;192(6):1023-8
pubmed: 16107955
Sci Rep. 2022 Jan 7;12(1):203
pubmed: 34997073
Bioessays. 2014 Oct;36(10):991-6
pubmed: 25100240
Appl Environ Microbiol. 2011 Feb;77(3):776-85
pubmed: 21148694
J Bacteriol. 2016 Dec 28;199(2):
pubmed: 27799328
Elife. 2017 Feb 21;6:
pubmed: 28221135
Bioinformatics. 2015 Jun 1;31(11):1708-15
pubmed: 25644268
Appl Environ Microbiol. 2015 May 1;81(9):3243-54
pubmed: 25747000
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Infect Immun. 2001 Dec;69(12):7851-7
pubmed: 11705967

Auteurs

Dustin R Long (DR)

Division of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

Kelsi Penewit (K)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Hsin-Yu Lo (HY)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Jared Almazan (J)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Elizabeth A Holmes (EA)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Andrew B Bryan (AB)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Daniel J Wolter (DJ)

Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.

Janessa D Lewis (JD)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Adam Waalkes (A)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Stephen J Salipante (SJ)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH